✦ LIBER ✦

Incidence of anemia in CHOP-treated intermediate-grade non-Hodgkin's lymphoma (IGNHL)

✍ Scribed by S. Gupta; R. Tannous; M. Fridman

Book ID: 117658200
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 168 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)80831-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of anemia in intermediate gra

Prevalence of anemia in intermediate grade non-Hodgkin's lymphoma (IGNHL)

✍ S. Gupta; R. Tannous; M. Fridman 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 186 KB

PCN1: BASELINE ANEMIA AND RISK OF POOR R

PCN1: BASELINE ANEMIA AND RISK OF POOR RESPONSE TO CHEMOTHERAPY IN INTERMEDIATE GRADE NON-HODGKIN'S LYMPHOMA(IGNHL) PATIENTS

✍ G Lawless; S Gupta; RE Tannous 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Chop treatment in eighty cases of interm

Chop treatment in eighty cases of intermediate and high grade non-Hodgkin's lymphomas

✍ Dallavalle, G.; Tedeschi, L.; Romanelli, A.; Labianca, R.; Luporini, G. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Clinical randomized comparative trial of

Clinical randomized comparative trial of DICE regimen and CHOP regimen in treating intermediate and high grade non-Hodgkin’s lymphoma

✍ Wenwu Wang; Xuenong OuYang; Zhangshu Cheng; Yonghai Peng; Fangwei Xie; Zongyang 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 169 KB

Long-term follow-up of CHOP-treated non-

Long-term follow-up of CHOP-treated non-Hodgkin lymphoma of high-grade malignancy

✍ Heinz, R. 📂 Article 📅 1990 🏛 Springer-Verlag ⚖ 861 KB

Management of advanced stage intermediat

Management of advanced stage intermediate grade non-Hodgkin's lymphomas

✍ Dr. Raymond H. S. Liang; Edmond K. W. Chiu; T. K. Chan; David Todd; S. L. Loke 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

The treatment result of271 cases ofadvanced stage intermediate grade lymphoma were reviewed. Ninety-four patients received CHOP chemotherapy, 45 BACOP and 17 m-BACOD. The clinical characteristics of the three groups of patients were comparable. Patients receiving CHOP had a complete response (CR) ra